A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis

Non ancora tradotto Non ancora tradotto
Autori
Categoria Primary study
Registry of TrialsClinicalTrials.gov
Year 2011
The study proposes to assess whether compared to placebo, CP-690,550 is effective, safe, and tolerable maintenance therapy in subjects with Ulcerative Colitis (UC). The study proposes to assess whether compared to placebo, CP-690,550 maintenance therapy more effectively achieves mucosal healing and improves quality of life in subjects with UC.The study proposes to assess CP-690,550 pharmacokinetic exposure during maintenance therapy in subjects over the age of 18 years with UC.
Epistemonikos ID: 15d395b6f69c3e7a2ac390a89466171e73b9f4ff
First added on: Mar 23, 2022